Understanding the NMD regulatory path from genetic variation to phenotypes

了解 NMD 从遗传变异到表型的调控路径

基本信息

  • 批准号:
    10594582
  • 负责人:
  • 金额:
    $ 32.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-05-01 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY There are fundamental gaps in our understanding of the regulatory mechanisms of nonsense- mediated mRNA decay (NMD). Originally conceived as a quality-control checkpoint to recognize and degrade aberrant transcripts, NMD has become appreciated as a post-transcriptional gene regulation mechanism to fine-tune expression of many non-aberrant endogenous mRNAs. However, despite a plethora of biochemical characterization on the NMD pathway, the mechanism of NMD regulation and the criteria for NMD target selection are poorly understood. Our long-term goal is to develop computational methods to discover the principles of gene expression regulation and explore how variations or defects in gene regulation cause phenotypic variation or disease. The overall objective of this application is to elucidate the context-dependent NMD regulation of individual genes through genetical genomics. Genetic variants associated with changes in gene expression (expression quantitative trait loci, eQTLs) are being catalogued in increasingly large-scale human studies, such as the Genotype-Tissue Expression (GTEx) project. We will take advantage of this unprecedented resource to dissect NMD control and to discover NMD regulatory rules in a systematic and unbiased manner. Traditional biochemical and molecular approaches are essential to deciphering NMD mechanism but are slow in progress with intrinsic limitations. Genetical genomics will provide a fresh view and has great promise to uncover new regulatory rules of NMD. We will develop novel statistical and computational methods tailored to the analysis of NMD regulation. These methods can also be broadly applied to studies of other regulatory variants. Our long-standing expertise in transcriptomics analysis, eQTL analysis, and NMD regulation places us in a unique position to accomplish the proposed project. The proposed methods meet the analysis challenges arising from transcriptomics, eQTL mapping, and RNA biology. The completion of this project will vertically advance and expand our understanding of how NMD regulates gene expression. Ultimately, such knowledge has the potential to develop NMD-based preventive and therapeutic interventions.
项目摘要 我们对废话的调节机制的理解存在根本性的差距- 介导的mRNA衰变(NMD)。最初设想为一个质量控制检查点, 并降解异常的转录本,NMD已被认为是一个转录后基因, 调节机制,以微调许多非异常内源性mRNA的表达。 然而,尽管对NMD途径有过多的生物化学表征, 对NMD的调控机制和NMD目标选择的标准知之甚少。 我们的长期目标是发展计算方法来发现基因的原理 表达调控,并探讨基因调控中的变异或缺陷如何导致 表型变异或疾病。本申请的总体目标是阐明本发明的实施例。 通过遗传基因组学对单个基因的背景依赖性NMD调控。遗传 与基因表达变化相关的变异(表达数量性状位点,eQTL) 在越来越大规模的人类研究中被编入目录,例如基因型组织 Expression(GTEx)项目。我们将利用这一前所未有的资源, NMD控制,并以系统和公正的方式发现NMD监管规则。 传统的生物化学和分子生物学方法是破解NMD的关键 机制,但进展缓慢,具有内在局限性。基因组学将提供一个 新的观点,并有很大的希望揭示新的管理规则的NMD。我们将开发 新的统计和计算方法,专门用于分析国家导弹防御系统的规定。这些 这些方法也可以广泛地应用于其它调节变体的研究。我们的长期 在转录组学分析,eQTL分析和NMD调控方面的专业知识使我们处于独特的 以完成拟议的项目。 所提出的方法满足了转录组学、eQTL 以及RNA生物学。这一项目的建成将纵向推进,扩大 我们对NMD如何调节基因表达的理解。最终,这些知识 开发基于NMD的预防和治疗干预措施的潜力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Liang Chen其他文献

Liang Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Liang Chen', 18)}}的其他基金

Investigate the immune modulation function of SARS-CoV-2 accessory protein ORF8
研究SARS-CoV-2辅助蛋白ORF8的免疫调节功能
  • 批准号:
    469610
  • 财政年份:
    2022
  • 资助金额:
    $ 32.06万
  • 项目类别:
    Operating Grants
COVID-19 Variant Supplement - Understand the high pathogenicity and zoonotic transmission of the COVID-19 virus: evasion of host innate immune responses
COVID-19 变异补充剂 - 了解 COVID-19 病毒的高致病性和人畜共患传播:逃避宿主先天免疫反应
  • 批准号:
    442863
  • 财政年份:
    2021
  • 资助金额:
    $ 32.06万
  • 项目类别:
    Operating Grants
Understand the high pathogenicity and zoonotic transmission of the COVID-19 virus: evasion of host innate immune responses
了解 COVID-19 病毒的高致病性和人畜共患传播:逃避宿主先天免疫反应
  • 批准号:
    422747
  • 财政年份:
    2020
  • 资助金额:
    $ 32.06万
  • 项目类别:
    Operating Grants
Understanding the NMD regulatory path from genetic variation to phenotypes
了解 NMD 从遗传变异到表型的调控路径
  • 批准号:
    10377405
  • 财政年份:
    2020
  • 资助金额:
    $ 32.06万
  • 项目类别:
Sex as a Biological Variable Supplement - Understand the high pathogenicity and zoonotic transmission of the COVID-19 virus: evasion of host innate immune responses
性别作为生物变量补充 - 了解 COVID-19 病毒的高致病性和人畜共患传播:逃避宿主先天免疫反应
  • 批准号:
    424691
  • 财政年份:
    2020
  • 资助金额:
    $ 32.06万
  • 项目类别:
    Operating Grants
Understanding the NMD regulatory path from genetic variation to phenotypes
了解 NMD 从遗传变异到表型的调控路径
  • 批准号:
    10714885
  • 财政年份:
    2020
  • 资助金额:
    $ 32.06万
  • 项目类别:
Novel approaches to identify regulators of Bak1 splicing
识别 Bak1 剪接调节因子的新方法
  • 批准号:
    10040977
  • 财政年份:
    2020
  • 资助金额:
    $ 32.06万
  • 项目类别:
Study IFITM restriction of HIV-1 entry: cross-talk with adaptive immunity
研究 IFITM 对 HIV-1 进入的限制:与适应性免疫的交叉对话
  • 批准号:
    401410
  • 财政年份:
    2019
  • 资助金额:
    $ 32.06万
  • 项目类别:
    Operating Grants
Overcome HIV-1 Resistance to CRISPR/Cas9 Attack
克服 HIV-1 对 CRISPR/Cas9 攻击的抵抗力
  • 批准号:
    350800
  • 财政年份:
    2016
  • 资助金额:
    $ 32.06万
  • 项目类别:
    Operating Grants
Genomic variation in epidemic carbapenem-resistant K.pneumoniae
流行性耐碳青霉烯类肺炎克雷伯菌的基因组变异
  • 批准号:
    9035583
  • 财政年份:
    2016
  • 资助金额:
    $ 32.06万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 32.06万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 32.06万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.06万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.06万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 32.06万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.06万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 32.06万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 32.06万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 32.06万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.06万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了